Editorial Standards

We prioritize regulator communications, registered clinical trials, primary peer-reviewed research, systematic reviews, and established medical references. Marketing claims, retailer copy, social posts, and personal anecdotes are not treated as proof of safety or effectiveness.

When evidence is early, indirect, animal-only, conflicting, or absent, the page should make that limitation clear. We avoid turning an association, mechanism, or preclinical finding into a clinical promise.

1. A topic and search intent are defined before drafting.
2. Claims are checked against the strongest available source type.
3. Approval status, uncertainty, contraindications, and safety signals are surfaced where relevant.
4. Titles and summaries are edited to avoid guarantees, fear, and unsupported health outcomes.
5. Material updates receive a new modification date.

The “PurePeptideHub Research Team” byline identifies an editorial team, not a medical credential. A page will only claim clinician or expert review when a named reviewer and their qualifications are displayed.

We update pages when material evidence, regulatory information, or safety guidance changes. Clear factual errors are corrected as quickly as practical. Readers can send a source and page address through our contact form.

Advertising, affiliate arrangements, sponsorships, or referral relationships must be disclosed clearly near the relevant content. Payment does not buy a positive conclusion, suppress a safety concern, or replace evidence. Paid links should be technically labeled for search engines where applicable.